Literature DB >> 3048338

Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.

K Hørslev-Petersen1, K Y Kim, L R Pedersen, K D Bentsen, N Uldbjerg, H Oxlund, C Garbarsch, E G Hahn, D Schuppan, I Lorenzen.   

Abstract

Serum aminoterminal type III procollagen peptide was measured in rats during the development of granulation tissue induced by subcutaneous implantation of viscose cellulose sponges. Active collagen type III synthesis in granulation tissue during the first three weeks was accompanied by an increase in serum propeptide level. A positive correlation was observed between the increase in serum propeptide level on the one hand and the increase in granulation tissue collagen type III content and the in vitro formation of tissue 3H-hydroxyproline on the other hand. In some animals the serum propeptide level remained low, despite biochemical signs of collagen synthesis, indicating variations in the release into serum and/or the metabolism of circulating propeptide. The increase in propeptide antigen concentration was mainly due to an elevated content of material with molecular weight equal to or twice that of the propeptide. A minor fraction of the propeptide remained attached to the interstitial collagen fibres in the granulation tissue. The correlation between the serum propeptide level and the biosynthesis of collagen at the site of the focal fibroproliferative process suggests that the serum propeptide level may be a valuable indicator of fibrogenesis and thereby of disease activity in fibrotic conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048338

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

1.  Immunohistochemistry of the intercellular matrix components and the epithelio-mesenchymal junction of the human tooth germ.

Authors:  C Garbarsch; M E Matthiessen; B E Olsen; D Moe; S Kirkeby
Journal:  Histochem J       Date:  1994-02

2.  Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.

Authors:  K Hørslev-Petersen; K D Bentsen; P Junker; F K Mathiesen; T M Hansen; I Lorenzen
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

3.  Changes in collagen metabolites in serum after cemented hip and knee arthroplasty.

Authors:  S Joerring; L T Jensen
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

4.  Synovial fluid and serum concentrations of aminoterminal propeptide of type III procollagen in healthy volunteers and patients with joint disease.

Authors:  M Sharif; E George; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

5.  Synthesis of type I collagen in healing wounds in humans.

Authors:  K Haukipuro; J Melkko; L Risteli; M Kairaluoma; J Risteli
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

6.  The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.

Authors:  K Hørslev-Petersen; T Saxne; D Haar; B S Thomsen; K D Bentsen; P Junker; I Lorenzen
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events.

Authors:  Cheng-Hung Lee; Wen-Chen Lee; Shang-Hung Chang; Ming-Shien Wen; Kuo-Chun Hung
Journal:  PLoS One       Date:  2015-01-05       Impact factor: 3.240

8.  Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats.

Authors:  Shaojun Ma; Xiaojiang Li; Liang Dong; Jinli Zhu; He Zhang; Yingjie Jia
Journal:  BMC Complement Altern Med       Date:  2016-02-11       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.